Regenxbio Market Sentiment

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,593.25+0.81%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Premium

Regenxbio Inc

RGNXNASDAQ

Trade with Public

$8.07

-0.02-0.25%

Last update: Oct 9, 7:48 PM

$8.08

-0.01-0.12%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Regenxbio Market Sentiment

Market sentiment signals for Regenxbio (RGNX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 15.4% short float

Options Flow▲ 0.10 P/C ratio

Insider Activity— N/A

Analyst Consensus

Outperform

15 analysts

Options Flow (P/C)

0.10

More calls — Bullish

365 calls · 37 puts

Avg Consensus PT

$24

+192.9%

Highest Price Target

$50

+518.8%

Chardan Capital

Lowest Price Target

$12

+48.5%

Barclays

Short Interest

15.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 5, 2026	Mizuho	Graig Suvannavejh—	+172.3%	$22	Initiate	Outperform
Aug 25, 2026	HC Wainwright & Co.	Yi Chen—	+159.9%	$23 → $21	Maintained	Buy
Aug 25, 2026	Baird	Brian Skorney—	+258.9%	$32 → $29	Maintained	Outperform
Aug 10, 2026	HC Wainwright & Co.	Yi Chen—	+184.7%	$26 → $23	Maintained	Buy
Aug 7, 2026	Barclays	Eliana Merle—	+48.5%	$12 → $12	Downgrade	Overweight→Equal-Weight
Jun 24, 2026	HC Wainwright & Co.	Yi Chen—	+221.8%	$26 → $26	Maintained	Buy
Jun 22, 2026	Baird	Brian Skorney—	+296.0%	$27 → $32	Maintained	Outperform
Jun 22, 2026	Leerink Partners	Mani Foroohar—	+122.8%	$17 → $18	Maintained	Outperform
Jun 5, 2026	HC Wainwright & Co.	Yi Chen—	+221.8%	$30 → $26	Maintained	Buy
May 15, 2026	B of A Securities	Geoff Meacham—	+73.3%	$25 → $14	Maintained	Buy
May 15, 2026	Barclays	Gena Wang—	+48.5%	$37 → $12	Maintained	Overweight
Mar 9, 2026	HC Wainwright & Co.	Yi Chen—	+271.3%	$32 → $30	Maintained	Buy
Mar 6, 2026	Morgan Stanley	Judah Frommer—	+110.4%	$18 → $17	Maintained	Overweight
Feb 10, 2026	HC Wainwright & Co.	Yi Chen—	+296.0%	$34 → $32	Maintained	Buy
Feb 10, 2026	Goldman Sachs	Paul Choi—	+48.5%	$14 → $12	Maintained	Neutral
Feb 10, 2026	Morgan Stanley	Judah Frommer—	+122.8%	$25 → $18	Maintained	Overweight
Feb 10, 2026	Chardan Capital	Daniil Gataulin—	+518.8%	$52 → $50	Maintained	Buy
Jan 29, 2026	Chardan Capital	Daniil Gataulin—	+543.6%	$52 → $52	Maintained	Buy
Dec 19, 2025	Stifel	Annabel Samimy—	+456.9%	$40 → $45	Maintained	Buy
Dec 15, 2025	Leerink Partners	Mani Foroohar—	+147.5%	$16 → $20	Maintained	Outperform
Nov 20, 2025	Chardan Capital	Daniil Gataulin—	+543.6%	$52 → $52	Maintained	Buy
Nov 7, 2025	RBC Capital	Luca Issi—	+135.1%	$17 → $19	Maintained	Outperform
Oct 7, 2025	HC Wainwright & Co.	Yi Chen—	+320.8%	$34 → $34	Maintained	Buy
Sep 8, 2025	HC Wainwright & Co.	Yi Chen—	+320.8%	$34 → $34	Maintained	Buy
Sep 8, 2025	Chardan Capital	Daniil Gataulin—	+543.6%	$52 → $52	Maintained	Buy